Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Operating Leases (2022 - 2025)

Biofrontera has reported Operating Leases over the past 4 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Operating Leases at $1.2 million for Q4 2025, up 349.28% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 349.28% YoY), and the annual figure for FY2025 was $1.2 million, up 349.28%.
  • Operating Leases for Q4 2025 was $1.2 million at Biofrontera, up from $136000.0 in the prior quarter.
  • Over the last five years, Operating Leases for BFRIW hit a ceiling of $1.2 million in Q4 2025 and a floor of $136000.0 in Q3 2025.
  • Median Operating Leases over the past 4 years was $502500.0 (2023), compared with a mean of $535166.7.
  • Biggest five-year swings in Operating Leases: tumbled 65.67% in 2024 and later surged 349.28% in 2025.
  • Biofrontera's Operating Leases stood at $848000.0 in 2022, then decreased by 5.19% to $804000.0 in 2023, then tumbled by 65.67% to $276000.0 in 2024, then skyrocketed by 349.28% to $1.2 million in 2025.
  • The last three reported values for Operating Leases were $1.2 million (Q4 2025), $136000.0 (Q3 2025), and $223000.0 (Q2 2025) per Business Quant data.